Sumitomo Chemical Company, Limited
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 11 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Major Holders
Updated 2026/01/11| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
21.6M | -0.37% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
13.7M | +2.62% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
10.1M | -0.34% | |
|
SCHWAB STRATEGIC TRUST-Schwab Fundamental International Equity ETF
|
5.2M | -6.57% | |
|
iShares Trust-iShares MSCI EAFE Small-Cap ETF
|
5.1M | +5.61% | |
|
Fidelity Salem Street TRT-Fidelity SAI Intl Value Index Fd.
|
4.2M | +1.00% |
Dividend History 1Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥12 | +100.0% |
| 2024 | ¥6 | -50.0% |
| 2023 | ¥12 | -53.8% |
| 2022 | ¥26 | +62.5% |
| 2021 | ¥16 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥2,765,321M | ¥2,895,283M | ¥2,446,893M | ¥2,606,281M |
| Gross Profit | ¥873,863M | ¥820,926M | ¥499,695M | ¥725,476M |
| Operating Income | ¥172,823M | -¥24,187M | -¥431,428M | ¥172,394M |
| Pretax Income | ¥274,197M | ¥39,852M | -¥415,829M | ¥210,683M |
| Net Income | ¥162,130M | ¥6,987M | -¥311,838M | ¥38,591M |
| EPS | ¥99.16 | ¥4.27 | -¥190.69 | ¥23.58 |
| Operating Margin | 6.25% | -0.84% | -17.63% | 6.61% |
| Balance Sheet | ||||
| Total Assets | ¥4,308,151M | ¥4,165,503M | ¥3,934,818M | ¥3,439,784M |
| Total Equity | ¥1,218,101M | ¥1,171,192M | ¥965,753M | ¥900,790M |
| Total Liabilities | ¥3,090,050M | ¥2,994,311M | ¥2,969,065M | ¥2,538,994M |
| Cash | ¥365,429M | ¥305,844M | ¥217,449M | ¥209,838M |
| Interest-bearing Debt | ¥1,350,470M | ¥1,461,366M | ¥1,563,486M | ¥1,286,128M |
| Equity Ratio | 28.27% | 28.12% | 24.54% | 26.19% |
| D/E Ratio | 1.11 | 1.25 | 1.62 | 1.43 |
| Cash Flow | ||||
| Operating CF | ¥171,715M | ¥111,621M | -¥51,317M | - |
| Investing CF | -¥115,421M | -¥19,411M | -¥112,240M | - |
| Financing CF | -¥81,394M | -¥178,502M | ¥49,246M | - |
| Free CF | ¥171,715M | -¥31,960M | -¥204,190M | - |
| Efficiency | ||||
| ROE | 13.31% | 0.60% | -32.29% | 4.28% |
| ROA | 3.76% | 0.17% | -7.93% | 1.12% |
Latest IR Information
-
(Disclosure Progress) Notice on the Determination of the Share Exchange Ratio in the Simplified Share Exchange between Sumitomo Chemical Company, Limited and Tanaka Chemical Laboratory Co., Ltd.
Sumitomo Chemical will allocate 0.87 shares for each share of Tanaka Chemical, and plans to execute the share exchange using approximately 14,028,356 shares of treasury stock.
Read more -
Notice Regarding the Execution of Business Integration Agreement and Joint Venture Agreement with Prime Polymer Co., Ltd., Mitsui Chemicals, Inc., and Idemitsu Kosan Co., Ltd. for the Integration of Domestic Polyolefin Business (PP, LLDPE) Accompanied by a Company Split (Simplified Absorption-Type Company Split) by Sumitomo Chemical Company, Limited
Sumitomo Chemical has signed a business integration agreement to integrate its domestic polyolefin PP and LLDPE businesses into Prime Polymer Co., Ltd. through a simplified absorption-type company split and will acquire 20% equity in the company.
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥525
Rating Score: 2.00 (Based on 11 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc. The ICT & Mobility Solutions segment provides optical products, semiconductor processing materials, compound semiconductor materials, touch screen sensor panels, high-purity aluminum and alumina, specialty chemicals, additives, engineering plastics, and battery materials, etc. The Advanced Medical Solutions segment offers contract development and manufacturing organization business for small-molecule active ingredients and intermediates, oligonucleic acid drug substances, and regenerative medicine, and cell therapy products, etc. The Essential & Green Materials segment offers synthetic resins, raw materials for synthetic fibers, various industrial chemicals, methyl methacrylate products, synthetic resin processed products, industrial aluminum and alumina, and synthetic rubber, etc. The Sumitomo Pharma segment offers small molecule pharmaceuticals. Sumitomo Chemical Company, Limited was founded in 1913 and is headquartered in Tokyo, Japan.
